European equities opened Monday with a split performance as investors await this week’s high-stakes Russia-U.S. summit, which some hope could pave the way toward ending the conflict in Ukraine.
The U.K.’s FTSE 100 managed a modest gain of 0.3%, while Germany’s DAX slipped 0.1%, and France’s CAC 40 edged down 0.2%.
Shares of German steel producer Salzgitter (TG:SZG) fell following a wider loss reported for Q2 and a lowered forecast for the full year.
Defense sector stocks also faced pressure after U.S. President Donald Trump hinted at a possible territorial exchange deal between Russia and Ukraine to resolve the war that has lasted over three years.
Building materials firm Marshalls (LSE:MSLH) declined after releasing half-year figures that showed a significant drop in profits.
In contrast, London-listed homebuilder Vistry Group (LSE:VTY) gained ground after confirming the continuation of its £130 million share repurchase program.
Pharmaceutical company GSK (LSE:GSK) also saw its stock rise after the U.S. FDA accepted its priority review application for gepotidacin, an oral antibiotic aimed at treating uncomplicated gonorrhea.
This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.
Leave a Reply